Frank I. Scott, MD
Gastroenterology
Locations
Practice Locations
UCHealth Digestive Health Center - Anschutz Medical Campus
720-848-2777
UCHealth Crohn’s and Colitis Center - Anschutz Medical Campus
720-848-2777
Provider Expertise
Care Philosophy
I strive to provide the best possible care for patients with inflammatory bowel disease, combining state-of-the-art medical therapy and diagnostic techniques to achieve the most personalized therapy for my patients.
Specialties
- Gastroenterology ( 2012 )
- Internal Medicine ( 2009 )
Conditions & Treatments
-
Digestive System
Inflammatory Bowel Disease (IBD): Crohn’s disease, ulcerative colitis, microscopic colitis
Interests & Activities
Personal Interests
In my free time, I am an avid cyclist, runner, and relatively poor swimmer. I also enjoy taking advantage of some of the best skiing terrain in North America.
Education & Training
Medical Schools
MD, Temple University School of Medicine (2006)
Undergraduate Schools
BA, University of Pennsylvania (Philadelphia, PA) (2000)
Graduate Schools
MSCE, University of Pennsylvania (2012)
Residency Program
New York Presbyterian Hospital (Cornell Campus) Program (2009)
Fellowships
Hospital of the University of Pennsylvania (2012)
Hospital of the University of Pennsylvania (2013)
Professional Memberships
American College of Gastroenterology (ACG), Member
American Gastroenterological Association (AGA), Member
Crohn's and Colitis Foundation of America (CCFA), Member, Research Initiatives Committee
Research & Grants
Grants
Microvascular Disease, Statins, ACE-Inhibitors, and Post-operative SBO (PI) (2012)
Fellowship in Inflammatory Bowel Disease (2012)
Patient Valued Comparative Effectiveness of Corticosteroids versus Anti-TNF alpha Therapy for Inflammatory Bowel Disease (Co-Investigator) (2013)
Modeling the Optimal Position of Newly Approved Therapies in Ulcerative Colitis (2015)
information for referring providers
Referral Contact Phone
720-848-2777
Clinical Interests for Referring Providers
My clinical interests include the medical and endoscopic management of the inflammatory bowel diseases (IBD), including Crohn's Disease, Ulcerative Colitis, and microscopic colitis.
Research Interest for Referring Providers
My research has been focused in inflammatory bowel diseases and pharmacoepidemiology. I have conducted studies assessing the safety of therapies in inflammatory bowel disease, in particular related to risk-benefit analyses assessing commonly used immunosuppressive medications in Crohn’s disease and ulcerative colitis. I am most interested in the impact of age and gender on the risk beneft balance of immunosuppressive therapies, as well as the positioning of new therapies in current treatment paradigms as they come to market in IBD. I am also involved in pharmacoepidemiologic research involving adhesion-related complications after surgery and examining the impact of antibiotic therapy on obesity in pediatric populations. My research experience includes the design and conduct of observational studies using large secondary datasets, validation studies to assess the viability and accuracy of specific datasets, and decision analysis including techniques such as Markov cohort analyses and discrete event simulation. I have developed particular skills utilizing The Health Improvement Network, a large secondary dataset derived from electronic medical records within the United Kingdom.
